Modifications on the carboxylic function of kynurenic acid
- 14 October 2011
- journal article
- research article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 119 (2) , 109-114
Abstract
Pharmacological and histological studies of ten new amides of kynurenic acid revealed that N-(2-N,N-dimethylaminoethyl)-4-oxo-1H-quinoline-2-carboxamide hydrochloride has effective neuroprotective properties. Namely, this molecule is: (1) proved to be an effective inhibitor of excitatory synaptic transmission in the CA1 region of the hippocampus both in in vitro and ex vivo studies, (2) in four vessel occlusion model of transient global forebrain ischaemia, measuring the rate of hippocampal CA1 pyramidal cell loss and preservation of long-term potentiation at Schaffer collateral-CA1 synapses, the neuroprotective potential was represented. N-(2-N,N-dimethylaminoethyl)-4-oxo-1H-quinoline-2-carboxamide hydrochloride administration significantly diminished hippocampal CA1 cell loss and preserved LTP expression.Keywords
This publication has 23 references indexed in Scilit:
- Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemiaEuropean Journal of Pharmacology, 2011
- Distribution, Synthesis, and Absorption of Kynurenic Acid in PlantsPlanta Medica, 2010
- 4-Quinolones: Smart Phones of the Microbial WorldChemical Reviews, 2010
- The Janus-face kynurenic acidJournal of Neural Transmission, 2008
- Presence of kynurenic acid in food and honeybee productsAmino Acids, 2008
- Neuroprotective effect of L-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbilsEuropean Journal of Pharmacology, 2007
- Kynurenic acid amides as novel NR2B selective NMDA receptor antagonistsBioorganic & Medicinal Chemistry Letters, 2007
- Kynurenic acid has a dual action on AMPA receptor responsesNeuroscience Letters, 2006
- Can the USP paddle method be used to represent in-vivo hydrodynamics?Journal of Pharmacy and Pharmacology, 2003
- Kynurenic acid antagonists and kynurenine pathway inhibitorsExpert Opinion on Investigational Drugs, 2001